Clinical Trials Browser

Observational × Breast Neoplasms × ribociclib × Clear all

NCT06930859 2026-04-20

ELEGANCE

Breast Neoplasms

NCT04943497 2026-04-01

PROSPERITY

Breast Neoplasms

NCT06830720 2026-04-01

CAROLEEN

Breast Neoplasms

NCT06905301 2026-04-01

IMPULSE

Breast Neoplasms

NCT05697146 2026-03-16

RosaLEE

Active not recruiting

Breast Neoplasms

NCT06797531 2026-02-04

NISLEESA

Breast Neoplasms

NCT06495164 2025-11-25

A Real-life Study to Understand the Use and Effects of Palbociclib in US Patients With Breast Cancer

Active not recruiting

Breast Neoplasms

NCT07072013 2025-07-18

IRINA

Breast Neoplasms

NCT07008508 2025-06-06

BRAVE-Cyclin

Active not recruiting

BreastClassical hematology

Breast Neoplasms, Cardiovascular Diseases, Venous Thromboembolism

NCT06805812 2025-02-03

PALMARES-2

Breast Diseases, Breast Neoplasms, Neoplasm Metastasis, Breast Neoplasms, Male

NCT06075758 2025-01-14

A Study of Ribociclib in Combination With Hormonal Therapy in HR+/HER2- Advanced or Metastatic Breast Cancer

Breast Neoplasms

NCT06587789 2024-11-21

Ribociclib in Combination With Adjuvant Endocrine Therapy for Patients With Early High-risk HR+HER2- Breast Cancer

Breast Neoplasms

NCT03956654 2024-08-09

RibOB

Breast Neoplasms

NCT05569187 2022-11-08

Ribociclib in Combination With Non-steroidal Aromatase Inhibitors in Patients With Advanced Breast Cancer

Breast Neoplasms

NCT05153135 2021-12-21

Description of Treatment Patterns and Description and Comparison of Healthcare Resource Utilization and Costs of Women With Metastatic HR+/HER2- Breast Cancer Treated With CDK4/6 Inhibitors

Breast Neoplasms

NCT04852081 2021-04-21

Analysis of Therapy Sequence in Women With HR+, HER2 - mBC in Moscow: A Multicenter Retrospective Observational Study.

Breast Neoplasms